<DOC>
	<DOCNO>NCT01159275</DOCNO>
	<brief_summary>The purpose study study pharmacokinetics profile generic lopinavir/ritonavir Pediatric AluviaÂ® reduce dose assess safety , tolerability efficacy .</brief_summary>
	<brief_title>Lopinavir ( LPV ) Dose Reduction</brief_title>
	<detailed_description>This prospective , 2 arm , randomize intensive PK study cross design . This design provide u optimal information answer research question . First important , assess PK lopinavir/r use dose reduced form . By randomize patient either Abbott 's pediatric Aluvia dose reduction India generic LPV/r dose reduction allow u assess difference AE severity frequency . Using standard abbott product control study provide important information bioavailability generic product . Although 's original BE design must able make preliminary comparison .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>1 . Signed informed consent 2 . Evidence HIV infection ( confirm positive ELISA and/or document history measurable HIV RNA ) 3 . Age &gt; 18 year 4 . Have standard dose PI contain regimen least 4 week prior study entry 5 . Currently AIDS define illness 6 . Plasma HIV RNA &lt; 50 copies/mL least 24 week 7 . Willing adhere protocol requirement 1 . Any history take CYP450 inhibitor inducer , gastric acidreducing drug within 14 day enrollment study 2 . Current pregnancy lactate 3 . Active opportunistic infection 4 . ALT/ AST 2x upper limit 5. creatinine 1.5 time upper limit 6 . Relevant history current condition , illness might interfere drug absorption , distribution , metabolism excretion 7 . History sensitivity/idiosyncrasy drug chemically related compound pharmaceutical excipients may employ study . 8 . Active drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>lopinavir/ritonavir</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>HIV-1 infect adult</keyword>
	<keyword>aim investigate low dose boost lopinavir Thais compare level lopinavir/ritonavir Abbot GPO</keyword>
</DOC>